Leslie V. Norwalk, Director: Neurocrine Biosciences NBIX Sell · Filed 24/05/21

Trade details

Type: Insider sale
Amount: $156,852.92
Shares · price: 1,106 sh · $141.82 a share
Held after: 994 sh
Stock: Neurocrine Biosciences NBIX
Person: Leslie V. NorwalkDirector
Trade date: 24/05/17
Filed: 24/05/21
Days to filing: 4 days

Sold 52.7% of holdings

Share of holding sold: 52.7%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 24/04/17~24/06/16

Leslie V. Norwalk's recent trades

Leslie V. NorwalkDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$210.1K
1,250 sh
$210.1K
Filed 06/08
Traded 06/04
Leslie V. NorwalkDirector
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$590.6K
3,810 sh
$590.6K
Filed 05/14
Traded 05/12
Leslie V. NorwalkDirector
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$1M
6,310 sh
$1M
Filed 05/12
Traded 05/12
Leslie V. NorwalkDirector
Sell10b5-1 planGlobus Medical
Sell10b5-1 plan
Globus Medical
GMED
$202.2K
2,000 sh
$202.2K
Filed 01/12
Traded 01/08
Leslie V. NorwalkDirector
Planned sale10b5-1 planGlobus Medical
Planned sale10b5-1 plan
Globus Medical
GMED
$202K
2,000 sh
$202K
Filed 01/08
Traded 01/08

Leslie V. Norwalk, Director — sold $156.9K of Neurocrine Biosciences NBIX · 52.7% of holdings · 10b5-1 plan | Whalegun